ArticleBreast cancer (Tokyo, Japan)2025

Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies.

Aya Imai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.